Meeting
2019 ASCO Annual Meeting
Surveillance in stage I MOGCTs (malignant ovarian germ cell tumors): A MITO prospective study (multicenter Italian trials in ovarian cancer).
Authors
Alice Bergamini
Università Vita-salute San Raffaele, Milan, Italy
Alice Bergamini , Giorgio Giorda , Gabriella Ferrandina , Gennaro Cormio , Domenica Lorusso , Chiara Cassani , Francesco Raspagliesi , Marco Marinaccio , Elena Bertone , Luigi Frigerio , Giovanna Scarfone , Myriam Perrone , Luca Bocciolone , Antonella Savarese , Sandro Pignata , Giorgia Mangili
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Ovarian Cancer
Citation
J Clin Oncol 37, 2019 (suppl; abstr 5516)
DOI
10.1200/JCO.2019.37.15_suppl.5516
Abstract #
5516
Poster Bd #
339
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
North American patterns of care in clinical stage I testicular cancer from SWOG S1823.
First Author: Antoine Morin Coulombe
Poster
2017 Genitourinary Cancers Symposium
111: A single-arm trial evaluating one cycle of BEP as adjuvant chemotherapy in high-risk, stage 1 non-seminomatous or combined germ cell tumors of the testis (NSGCTT).
First Author: Robert Anthony Huddart
Poster
2016 ASCO Annual Meeting
Sperm count in Swedish clinical stage I testicular cancer patients following modern adjuvant treatment.
First Author: Kristina Weibring
Poster
2013 ASCO Annual Meeting
One course of adjuvant BEP in clinical stage I, nonseminoma: Mature and expanded results from the SWENOTECA group.
First Author: Torgrim Tandstad